Theranos Faces New Challenges and Increasing Federal Scrutiny
Theranos continues to face challenges concerning its Newark, Calif., laboratory as its initial response to Centers for Medicare & Medicaid Services (CMS) failed to resolve inspection issues and the agency recommended the company’s CLIA certification be revoked for that California lab. CMS recommended that Theranos lose its CLIA certification unless the lab provides evidence that […]
This content is exclusive to Lab Compliance Advisor subscribers
Start a Free Trial for immediate access to this article and our entire archive of over 20 years of LCA reports.